Previous Close | 24.21 |
1-Year Change | 18.16% |
6-Months Change | 23.9% |
3-Months Change | 24.47% |
Moving Avg (50d) | 23.098 |
Moving Avg (200d) | 20.582 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 1.12B |
Beta (3-Years) | 0.92 |
Revenue Growth (ttm) | 15.79% |
Net Profit Margin (ttm) | -6.52% |
Return On Assets (ttm) | -3.21% |
EPS (ttm) | -1.19 |
PE Ratio (ttm) | -20.34 |
Dividend Yield | % |
Asset Description: | Avanos Medical, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-07-11 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
23.726 | 22.999 | 22.515 | 21.789 | 20.578 | 19.368 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |